These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2118427

  • 1. Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity.
    Tawada H, Sugiyama Y, Ikeda H, Yamamoto Y, Meguro K.
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1238-45. PubMed ID: 2118427
    [Abstract] [Full Text] [Related]

  • 2. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
    Griffin BW, McNatt LG, Chandler ML, York BM.
    Metabolism; 1987 May; 36(5):486-90. PubMed ID: 3106757
    [Abstract] [Full Text] [Related]

  • 3. Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.
    Sohda T, Mizuno K, Imamiya E, Tawada H, Meguro K, Kawamatsu Y, Yamamoto Y.
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3601-16. PubMed ID: 6819094
    [No Abstract] [Full Text] [Related]

  • 4. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel and potent aldose reductase inhibitors: 4-benzyl- and 4-(benzothiazol-2-ylmethyl)-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-2-ac etic acid derivatives.
    Aotsuka T, Hosono H, Kurihara T, Nakamura Y, Matsui T, Kobayashi F.
    Chem Pharm Bull (Tokyo); 1994 Jun; 42(6):1264-71. PubMed ID: 8069975
    [Abstract] [Full Text] [Related]

  • 7. Spiro oxazolidinedione aldose reductase inhibitors.
    Schnur RC, Sarges R, Peterson MJ.
    J Med Chem; 1982 Dec; 25(12):1451-4. PubMed ID: 6818344
    [Abstract] [Full Text] [Related]

  • 8. Sorbinil: a member of the novel class of spirohydantoin aldose reductase inhibitors.
    Sarges R, Peterson MJ.
    Metabolism; 1986 Apr; 35(4 Suppl 1):101-4. PubMed ID: 3083199
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Orally active aldose reductase inhibitors derived from bioisosteric substitutions on tolrestat.
    Wrobel J, Millen J, Sredy J, Dietrich A, Kelly JM, Gorham BJ, Sestanj K.
    J Med Chem; 1989 Nov; 32(11):2493-500. PubMed ID: 2509709
    [Abstract] [Full Text] [Related]

  • 11. In vitro study of aldose reductase inhibitor concentrations in the lens and inhibitory effect on sugar alcohol accumulation.
    Yamamoto Y, Ohtori A.
    Curr Eye Res; 1990 May; 9(5):421-8. PubMed ID: 2116955
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Computer-assisted design and synthesis of novel aldose reductase inhibitors.
    Butera J, Bagli J, Doubleday W, Humber L, Treasurywala A, Loughney D, Sestanj K, Millen J, Sredy J.
    J Med Chem; 1989 Apr; 32(4):757-65. PubMed ID: 2539477
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Adv Exp Med Biol; 1979 Apr; 119():347-56. PubMed ID: 115231
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.